CD4 and Miyoshi myopathy: ROC curve and associated AUC analysis showed that the percentage of CD4+FOXP3+ T cells at the day of engraftment was a significant marker for early relapse or progression in MM patients: AUC was 0.72 (95% CI: 0.570—0.878; р=0.026) (Figure 3).